Potential ways to enhance ADR reporting given current concerns : enhancing ADR reporting

Sefah, Israel and Godman, Brian (2021) Potential ways to enhance ADR reporting given current concerns : enhancing ADR reporting. Advances in Human Biology, 11 (2). pp. 137-140. ISSN 2321-8568

[thumbnail of Sefah-Godman-AHB-2021-Potential-ways-to-enhance-ADR-reporting-given-current-concerns]
Preview
Text (Sefah-Godman-AHB-2021-Potential-ways-to-enhance-ADR-reporting-given-current-concerns)
Sefah_Godman_AHB_2021_Potential_ways_to_enhance_ADR_reporting_given_current_concerns.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial-ShareAlike 4.0 logo

Download (432kB)| Preview

    Abstract

    In previous commentaries, we discussed potential ways to enhance the quality and efficiency of medicine use amongst all key stakeholder groups and across health‑care sectors.[1,2] We would now like to focus on adverse drug reactions (ADRs), which can be defined as harmful or unpleasant unintended reactions, resulting from the use of medicines occurring at doses normally used in man.[3,4] Adverse drug events (ADEs) are now commonly used as a wider term than ADRs, defined as an injury resulting from the use of a medicine; however, not necessarily causally related to that medicine.[3,5,6] ADEs incorporate a number of areas including ADRs, drug allergies, medication errors, and overdoses.